PHARMACOKINETIC ANALYSES OF LEDIPASVIR/SOFOSBUVIR IN HCV-INFECTED SUBJECTS WITH ADVANCED LIVER DISEASE AND/OR FOLLOWING LIVER TRANSPLANTATION

被引：0
|
作者：
Garrison, K. L. [1 ]
German, P. [1 ]
Arterburn, S. [1 ]
De-Oertel, S. [1 ]
Brainard, D. [1 ]
Ling, J. [1 ]
Jin, F. [1 ]
Mathias, A. [1 ]
机构：
[1] Gilead, Foster City, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01538-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-198
引用
收藏
页码：S789 / S789
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of Once Daily Sofosbuvir or Ledipasvir/Sofosbuvir in HCV-Infected Adolescents
    Kirby, Brian
    German, Polina
    Kanwar, Bittoo
    Ni, Liyun
    Lakatos, Isobel
    Ling, John
    Mathias, Anita
    HEPATOLOGY, 2015, 62 : 1040A - 1041A
  • [2] Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
    Charlton, Michael
    Everson, Gregory T.
    Flamm, Steven L.
    Kumar, Princy
    Landis, Charles
    Brown, Robert S., Jr.
    Fried, Michael W.
    Terrault, Norah A.
    O'Leary, Jacqueline G.
    Vargas, Hugo E.
    Kuo, Alexander
    Schiff, Eugene
    Sulkowski, Mark S.
    Gilroy, Richard
    Watt, Kymberly D.
    Brown, Kimberly
    Kwo, Paul
    Pungpapong, Surakit
    Korenblat, Kevin M.
    Muir, Andrew J.
    Teperman, Lewis
    Fontana, Robert J.
    Denning, Jill
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brandt-Sarif, Theo
    Pang, Phillip S.
    McHutchison, John G.
    Reddy, K. Rajender
    Afdhal, Nezam
    GASTROENTEROLOGY, 2015, 149 (03) : 649 - 659
  • [3] Sofosbuvir and ribavirinin in hcv-infected patients listed for liver transplantation: a cost-effectiveness analysis
    Cortesi, Paolo A.
    Mantovani, Lorenzo G.
    Ciaccio, Antonio
    Rota, Matteo
    Cesana, Giancarlo
    Strazzabosco, Mario
    Belli, Luca S.
    HEPATOLOGY, 2014, 60 : 534A - 534A
  • [4] THE COST-EFFECTIVENESS OF SOFOSBUVIR AND RIBAVIRIN TREATMENT IN HCV-INFECTED PATIENTS LISTED FOR LIVER TRANSPLANTATION
    Cortesi, P. A.
    Mantovani, L.
    Ciaccio, A.
    Rota, M.
    Cesana, G.
    Strazzabosco, M.
    Belli, L. S.
    VALUE IN HEALTH, 2014, 17 (07) : A367 - A367
  • [5] PHARMACOKINETICS OF ONCE-DAILY SOFOSBUVIR OR LEDIPASVIR/SOFOSBUVIR IN HCV-INFECTED PEDIATRICS AGED 3 TO
    Begley, Rebecca
    Meng, Amy
    Massetto, Benedetta
    Shao, Jiang
    Yip, Christina Sze Man
    Ling, John
    Mathias, Anita
    GUT, 2019, 68 : A137 - A138
  • [6] Pharmacokinetic Analyses of Ledipasvir/Sofosbuvir and HIV Antiviral Regimens in Subjects with HCV/HIV Co-infection
    German, Polina
    Ni, Liyun
    Stamm, Luisa M.
    Yang, Jenny C.
    Lenoci, Maryanne
    Ling, John
    Mathias, Anita
    HEPATOLOGY, 2015, 62 : 768A - 769A
  • [7] TRANSPLANTATION Steroid use in HCV-infected liver transplant recipients
    Roche, Bruno
    Samuel, Didier
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (04) : 198 - 200
  • [8] ROLE OF LIVER BIOPSY IN ASSESSMENT OF LIVER DYSFUNCTION IN HCV-INFECTED CHILDREN FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
    El-Sayed, M. H.
    Ibrahim, D.
    Omar, W.
    Zalata, K.
    El-Haddad, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S558 - S558
  • [9] Treatment of HCV-recurrence after liver transplantation with sofosbuvir/ledipasvir: the role of ribavirin
    Eurich, Dennis
    Globke, Brigitta
    Nathanael, Raschzok
    Teegen, Eva
    Dimrah, Iman
    Schott, Eckart
    Pratschke, Johann
    TRANSPLANTATION, 2016, 100 (07) : S274 - S274
  • [10] RESISTANCE ANALYSES FOR LEDIPASVIR/SOFOSBUVIR CONTAINING REGIMENS IN PATIENTS INFECTED WITH CHRONIC HCVWHOHAVE ADVANCED LIVER DISEASE OR ARE POST LIVER TRANSPLANT (SOLAR-1 & 2 STUDIES)
    Charlton, M.
    Manns, M.
    Dvory-Sobol, H.
    Svarovskaia, E.
    Doehle, B.
    Arterburn, S.
    Yun, C.
    Brainard, D. M.
    Mchutchison, J. G.
    Miller, M. D.
    Mo, H.
    Afdhal, N.
    Mutimer, D.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S186 - S186
12345